The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages

Tissue Engineering - Part A

Volumn 17, Issue 19-20, 2011, Pages 2463-2471

  Hanson, Summer E ^a   King, Suzanne N ^a   Kim, Jaehyup ^a   Chen, Xia ^a   Thibeault, Susan L ^a   Hematti, Peiman ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL MEMBRANES; FLOW CYTOMETRY; FLOWCHARTING; GELS; HYDROGELS; MACROPHAGES; ORGANIC ACIDS; POLYSTYRENES; TISSUE; TISSUE CULTURE;

ACTIVATED MACROPHAGES; ANIMAL STUDIES; ANTI-INFLAMMATORIES; CELL SURFACE MARKER; CLINICAL TRIAL; CO-CULTURE SYSTEM; DIRECT CONTACT; EX-VIVO; EXTRACELLULAR MATRICES; HUMAN LEUKOCYTE ANTIGEN; HYALURONIC ACIDS; IMMUNOPHENOTYPES; IN-VITRO; MESENCHYMAL STROMAL CELLS; MONOCYTE-DERIVED MACROPHAGES; PARACRINE; PERIPHERAL BLOOD; THERAPEUTIC MODALITY; TISSUE CULTURE POLYSTYRENES; TISSUE REGENERATION; TISSUE REPAIR;

SCAFFOLDS (BIOLOGY);

ANIMALIA;

CD14 ANTIGEN; CELL SURFACE RECEPTOR; FC RECEPTOR; HLA DR ANTIGEN; HYALURONIC ACID; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; TISSUE SCAFFOLD;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; COCULTURE; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HYDROGEL; IMMUNOLOGY; IMMUNOPHENOTYPING; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MONOCYTE;

ANTIGENS, CD14; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; HYALURONIC ACID; HYDROGEL; IMMUNOPHENOTYPING; LECTINS, C-TYPE; MACROPHAGES; MANNOSE-BINDING LECTINS; MESENCHYMAL STROMAL CELLS; MONOCYTES; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; TISSUE SCAFFOLDS;

EID: 80053121333     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0716     Document Type: Article

References (41)

1. Christensen, L.H. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 35, 1612, 2009.
2. Duflo, S., Thibeault, S.L., Li, W., Shu, X.Z., and Prestwich, G. Effect of a synthetic extracellular matrix on vocal fold lamina propria gene expression in early wound healing. Tissue Eng 12, 3201, 2006.
3. Hanson, S.E., Bentz, M.L., and Hematti, P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 125, 510, 2010.
4. Hanson, S., Thibeault, S.L., and Hematti, P. Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction. Curr Stem Cell Res Ther 5, 268, 2010.
5. Caplan, A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213, 341, 2007.
6. Caplan, A.I. Mesenchymal stem cells. J Orthop Res 9, 641, 1991.
7. Hanson, S.E., Kim, J., Johnson, B.H., Bradley, B., Breunig, M.J., Hematti, P., and Thibeault, S.L. Characterization of mesenchymal stem cells from human vocal fold fibroblasts. Laryngoscope 120, 546, 2010.
8. da Silva Meirelles, L., Chagastelles, P.C., and Nardi, N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119, 2204, 2006.
9. Noel, D., Caton, D., Roche, S., Bony, C., Lehmann, S., Casteilla, L., Jorgensen, C., and Cousin, B. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 314, 1575, 2008.
10. Uccelli, A., Pistoia, V., and Moretta, L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28, 219, 2007.
11. Tolar, J., Le Blanc, K., Keating, A., and Blazar, B.R. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28, 1446, 2010.
12. Hematti, P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 22, 262, 2008.
13. Laurila, J.P., Laatikainen, L., Castellone, M.D., Trivedi, P., Heikkila, J., Hinkkanen, A., Hematti, P., and Laukkanen, M.O. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 11, 726, 2009.
14. Nauta, A.J., and Fibbe, W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499, 2007.
15. Battiwalla, M., and Hematti, P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11, 503, 2009.
16. Kim, J., and Hematti, P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37, 1445, 2009.
17. Pollard, J.W. Trophic macrophages in development and disease. Nat Rev Immunol 9, 259, 2009.
18. Mosser, D.M., and Edwards, J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958, 2008.
19. Chen, X., and Thibeault, S.L. Novel isolation and biochemical characterization of immortalized fibroblasts for tissue engineering vocal fold lamina propria. Tissue Eng Part C Methods 15, 201, 2009.
20. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D.J., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8, 315, 2006.
21. Duflo, S., Thibeault, S.L., Li, W., Shu, X.Z., and Prestwich, G.D. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng 12, 2171, 2006.
22. Thibeault, S.L., Klemuk, S.A., Chen, X., and Quinchia Johnson, B.H. In vivo engineering of the vocal fold ECM with injectable HA hydrogels-late effects on tissue repair and biomechanics in a rabbit model. J Voice 25, 249, 2010.
23. Thibeault, S.L., Li, W., and Bartley, S. A method for identification of vocal fold lamina propria fibroblasts in culture. Otolaryngol Head Neck Surg 139, 816, 2008.
24. Chen, X., and Thibeault, S.L. Biocompatibility of a synthetic extracellular matrix on immortalized vocal fold fibroblasts in 3-D culture. Acta Biomater 6, 2940, 2010.
25. Shu, X.Z., Liu, Y., Luo, Y., Roberts, M.C., and Prestwich, G.D. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules 3, 1304, 2002.
26. Shu, X.Z., Liu, Y., Palumbo, F., and Prestwich, G.D. Disulfide- crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 24, 3825, 2003.
27. Martin, P. Wound healing-aiming for perfect skin regeneration. Science 276, 75, 1997.
28. Matheson, L.A., Santerre, J.P., and Labow, R.S. Changes in macrophage function and morphology due to biomedical polyurethane surfaces undergoing biodegradation. J Cell Physiol 199, 8, 2004.
29. Shin, H. Fabrication methods of an engineered microenvironment for analysis of cell-biomaterial interactions. Biomaterials 28, 126, 2007.
30. McBane, J.E., Ebadi, D., Sharifpoor, S., Labow, R.S., and Santerre, J.P. Differentiation of monocytes on a degradable, polar, hydrophobic, ionic polyurethane: two-dimensional films vs. three-dimensional scaffolds. Acta Biomater 7, 115, 2011.
31. Thibeault, S.L., Klemuk, S.A., Smith, M.E., Leugers, C., and Prestwich, G. In vivo comparison of biomimetic approaches for tissue regeneration of the scarred vocal fold. Tissue Eng Part A 15, 1481, 2009.
32. Prestwich, G.D. Engineering a clinically-useful matrix for cell therapy. Organogenesis 4, 42, 2008.
33. Prestwich, G.D., and Kuo, J.W. Chemically-modified HA for therapy and regenerative medicine. Curr Pharm Biotechnol 9, 242, 2008.
34. Sanchez-Torres, C., Garcia-Romo, G.S., Cornejo-Cortes, M.A., Rivas-Carvalho, A., and Sanchez-Schmitz, G. CD16 + and CD16-human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4 + T cells. Int Immunol 13, 1571, 2001.
35. Ziegler-Heitbrock, L. The CD14 + CD16 + blood monocytes: their role in infection and inflammation. J Leukoc Biol 81, 584, 2007.
36. Allen, M.L., Peters, M.J., Goldman, A., Elliott, M., James, I., Callard, R., and Klein, N.J. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 30, 1140, 2002.
37. Payen, D., Faivre, V., Lukaszewicz, A.C., and Losser, M.R. Assessment of immunological status in the critically ill. Minerva Anestesiol 66, 757, 2000.
38. Martinez, F.O., Sica, A., Mantovani, A., and Locati, M. Macrophage activation and polarization. Front Biosci 13, 453, 2008.
39. Gordon, S., and Martinez, F.O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593, 2010.
40. Brown, B.N., Valentin, J.E., Stewart-Akers, A.M., McCabe, G.P., and Badylak, S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30, 1482, 2009.
41. Valentin, J.E., Stewart-Akers, A.M., Gilbert, T.W., and Badylak, S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 15, 1687, 2009.